Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 7,280,151 |
|
|||||
| News | - | ||||||
| Day High | 0.0007 | Low High |
|||||
| Day Low | 0.0006 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Globestar Therapeutics Corporation (PK) | GSTC | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0002 | -25.00% | 0.0006 | 16:08:53 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0007 | 0.0006 | 0.0007 | 0.0006 | 0.0008 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18 | 7,280,151 | $ 0.000628 | $ 4,568 | - | 0.0004 - 0.00815 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:47:55 | 150,000 | $ 0.0006 | USD |
Globestar Therapeutics Corporation (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 523.36k | 872.27M | 446.54M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Globestar Therapeutics (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GSTC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0007 | 0.0008 | 0.0006 | 0.0007784 | 554,444 | -0.0001 | -14.29% |
| 1 Month | 0.0005 | 0.0008 | 0.0005 | 0.0006629 | 2,040,493 | 0.0001 | 20.00% |
| 3 Months | 0.0023 | 0.0025 | 0.0004 | 0.0006978 | 8,639,070 | -0.0017 | -73.91% |
| 6 Months | 0.0011 | 0.0025 | 0.0004 | 0.0009919 | 10,684,926 | -0.0005 | -45.45% |
| 1 Year | 0.0056 | 0.00815 | 0.0004 | 0.0014397 | 7,808,901 | -0.005 | -89.29% |
| 3 Years | 0.073 | 0.073 | 0.0004 | 0.0061922 | 5,118,251 | -0.0724 | -99.18% |
| 5 Years | 0.073 | 0.073 | 0.0004 | 0.0061922 | 5,118,251 | -0.0724 | -99.18% |
Globestar Therapeutics (PK) Description
| GlobeStar Therapeutics Corporation ("GlobeStar"), headquartered in Richland, Washington, was incorporated in 2016 and owns breakthrough addition of treatment for Multiple Sclerosis and other neurodegenerative diseases as well other pharmaceuticals and nutraceutical. GlobeStar is a clinical stage pharmaceutical company testing a worldwide patented formulation of 3 drugs previously approved by the FDA. Pre-clinical trials in Italy showed the drug combination was effective in the reduction of MS co-morbidities. GlobeStar is initiating discussions with the FDA on clinical trial design in the U.S. in preparation for FDA submission and approval. |
